What Criteria Must a Drug Meet for Accelerated Approval?
To qualify for accelerated approval, a drug must demonstrate potential to address an unmet medical need for a serious condition like cancer. This often involves showing significant improvement over existing treatments based on surrogate endpoints such as tumor shrinkage or biomarker changes. The drug must also undergo rigorous post-approval studies to confirm its clinical benefit, ensuring that the initial approval is justified.
